Error: Could not add to watchlist. X
+ Watchlist

BriaCell Therapeutics Corp

BCTXF:US
OTC US
0.14
USD
0.00
0.00%
As of 8:10 PM EDT 9/18/2017
Volume
400
Previous Close
0.14
52Wk Range
0.11 - 0.18
1 Yr Return
-17.99%
Before it's here, it's on the Bloomberg Terminal.
Learn More
Volume
400
Previous Close
0.14
52Wk Range
0.11 - 0.18
1 Yr Return
-17.99%
YTD Return
-7.60%
Current P/E Ratio (TTM)
-
Earnings per Share (CAD) (TTM)
-
Market Cap (m USD)
15.241
Shares Outstanding (m)
109.963
Price/Sales (TTM)
-
Dividend Indicated Gross Yield
-
Sector
Health Care
% Price Change
+0.17%
% Price Change
+0.40%

Related Videos

There are currently no related videos for this ticker. Please check back later.
There are currently no news stories for this ticker. Please check back later.
There are currently no press releases for this ticker. Please check back later.
Profile
BriaCell Therapeutics Corp. operates as a breast cancer immunotherapy biotech research and developer. The Company developed a patented whole-cell vaccine, cancer immunotherapy technology called the "BriaVax" vaccine. BriaCell has offices in North America.
Address
Bellevue Center 235
15th Street
Vancouver, BC V7T 2X1
Canada
Phone
1-604-921-1810
Show More